Business
Sol-Gel is trying to improve acne and rosacea treatments using nanoscale particles. Businessman Mori Arkin is in advanced talks to buy Sol-Gel, which...
Hi, what are you looking for?
Israel High Tech Scene April 26 – May 2 New Startups / VC Funding Lightrun Secures $70M Series B to Lead Developer Observability Market...
Since last year’s Independence Day, Israel’s population has grown by 135,000, reflecting a 1.4% annual growth rate.
Water ice on the Moon could play a crucial role in establishing sustainable lunar habitats, providing water for astronauts and a potential source of...
Sol-Gel is trying to improve acne and rosacea treatments using nanoscale particles. Businessman Mori Arkin is in advanced talks to buy Sol-Gel, which...
– A partner in Standard General said new stores and a better website can help turn American Apparel around. – Standard General, the hedge...
– Screenz is answering the evolving TV industry needs with new ways of engaging viewers. – Screenz, an Israeli cross-media company developing complementary...
– The Oscar winning producer of “A Beautiful Mind” and “Apollo 13” still has to troll for funding like the rest of us. –...
– The Transport Minister said that civil servants should only fly on Israeli airlines. Managers of foreign airlines operating in Israel are...
– Argentina and its bankers have been barred from making payments to fulfill debt-restructuring agreements reached with the country’s creditors, unless the 7% of...
New update to ConceptDraw PRO of Accounting and Audit Flowcharts provide expanded capabilities to describe processes that relate to a companys business.
Successful FAA Trial Announced of Laufer WindRadar-Activated Obstruction Lighting SystemMajor Step Forward for Radar-Activated Lighting for Wind Farms
Scientists have discovered a substance artificially stimulating intensive production of love hormone. The working title of the substance is ISO Infinitum.
Avail is conducting a Phase 2 clinical research study to evaluate an experimental spray treatment for participants with mild to moderate OA of the...